The Filing Desk

biote vs LifeMD

biote BTMD · LifeMD LFMD · Health Care Services

LifeMD reported revenue of $194 million in fiscal 2025, about the same as biote's $192 million in fiscal 2025. biote's revenue fell 2.5% in its latest year, and LifeMD's grew 25.3%. biote had an operating margin of 18.5%, against -4.0% at LifeMD. Free cash flow was $30 million at biote and $6 million at LifeMD.

Side by side

bioteLifeMD
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$192M$194M
Revenue growth−2.5%25.3%
Revenue growth a year, last 5 years—39.1%
Gross margin—85.7%
Operating margin18.5%−4.0%
Net margin14.1%7.4%
Free cash flow$30M$6M
Free cash flow margin15.7%3.3%
Return on capital——
Net debt to EBITDA2.0x—
Dividends and buybacks$5M$3M
Change in diluted share count7.0%9.6%
Last close$0.84$1.59
P/E at the last close——
Insider trades, last 12 monthsbought $202,204, sold $0sold $54,150
Piotroski F-score5 of 8—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
bioteLifeMD
Operating margin
Percent of revenue
bioteLifeMD
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
bioteLifeMD

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the biote and LifeMD pages.